These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19823725)

  • 1. Detection of prostate specific antigen with nanomechanical resonators.
    Waggoner PS; Varshney M; Craighead HG
    Lab Chip; 2009 Nov; 9(21):3095-9. PubMed ID: 19823725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-situ quantitative analysis of a prostate-specific antigen (PSA) using a nanomechanical PZT cantilever.
    Hwang KS; Lee JH; Park J; Yoon DS; Park JH; Kim TS
    Lab Chip; 2004 Dec; 4(6):547-52. PubMed ID: 15570363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bio-barcode assay for on-chip attomolar-sensitivity protein detection.
    Goluch ED; Nam JM; Georganopoulou DG; Chiesl TN; Shaikh KA; Ryu KS; Barron AE; Mirkin CA; Liu C
    Lab Chip; 2006 Oct; 6(10):1293-9. PubMed ID: 17102842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samples.
    Panini NV; Messina GA; Salinas E; Fernández H; Raba J
    Biosens Bioelectron; 2008 Feb; 23(7):1145-51. PubMed ID: 18162392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay of prostate-specific antigen (PSA) using resonant frequency shift of piezoelectric nanomechanical microcantilever.
    Lee JH; Hwang KS; Park J; Yoon KH; Yoon DS; Kim TS
    Biosens Bioelectron; 2005 Apr; 20(10):2157-62. PubMed ID: 15741091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic chip-based nanoelectrode array as miniaturized biochemical sensing platform for prostate-specific antigen detection.
    Triroj N; Jaroenapibal P; Shi H; Yeh JI; Beresford R
    Biosens Bioelectron; 2011 Feb; 26(6):2927-33. PubMed ID: 21190835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology.
    Huhtinen P; Soukka T; Lövgren T; Härmä H
    J Immunol Methods; 2004 Nov; 294(1-2):111-22. PubMed ID: 15604021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic whole blood plasmapheresis chip for prostate specific antigen microarray diagnostics.
    Lenshof A; Ahmad-Tajudin A; Järås K; Swärd-Nilsson AM; Aberg L; Marko-Varga G; Malm J; Lilja H; Laurell T
    Anal Chem; 2009 Aug; 81(15):6030-7. PubMed ID: 19594154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection.
    Solassol J; Marin P; Demettre E; Rouanet P; Bockaert J; Maudelonde T; Mangé A
    Anal Biochem; 2005 Mar; 338(1):26-31. PubMed ID: 15707932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro OS-ELISA: Rapid noncompetitive detection of a small biomarker peptide by open-sandwich enzyme-linked immunosorbent assay (OS-ELISA) integrated into microfluidic device.
    Ihara M; Yoshikawa A; Wu Y; Takahashi H; Mawatari K; Shimura K; Sato K; Kitamori T; Ueda H
    Lab Chip; 2010 Jan; 10(1):92-100. PubMed ID: 20024056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen detection by ultrasensitive assay in samples from women.
    Filella X; Molina R; Alcover J; Menéndez V; Giménez N; Jo J; Carretero P; Ballesta AM
    Prostate; 1996 Nov; 29(5):311-6. PubMed ID: 8899004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry.
    Finnskog D; Jaras K; Ressine A; Malm J; Marko-Varga G; Lilja H; Laurell T
    Electrophoresis; 2006 Mar; 27(5-6):1093-103. PubMed ID: 16523454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
    Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W
    Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples.
    Egawa S; Suyama K; Matsumoto K; Kuwao S; Baba S
    J Urol; 2002 Jan; 167(1):97-102. PubMed ID: 11743284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between CD8+ T cells specific for prostate-specific antigen and level of disease in patients with prostate cancer.
    Elkord E; Rowbottom AW; Kynaston H; Williams PE
    Clin Immunol; 2006 Jul; 120(1):91-8. PubMed ID: 16458609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate-specific antigen].
    Eide IA; Angelsen A
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2528-31. PubMed ID: 11070990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.